Breast Cancer Test Rates Drug Therapy Candidates (HealthDay)
Font size:
HealthDay - TUESDAY, July 8 (HealthDay News) -- The U.S. Food and Drug
Administration has approved a genetic test designed to evaluate whether a
person with breast cancer is a good candidate for treatment with the drug
Herceptin (trastuzumab).
Add to:
del.icio.us |
Digg
del.icio.us |
Digg
Email to a friend
Print version
Plain textRate this article
Comments (0 posted):
Post your comment